EGFR and breast carcinoma: EGFR‐CAR NK‐92 cells increased cytolytic effect and IFN‐γ production in breast cancer cell lines MDA‐MB‐231, MDA‐MB‐468, and MCF‐7(in vitro) and mitigated tumour growth in tumour‐bearing mice (in vivo)